https://ift.tt/3hzBSQP
Submitted July 23, 2020 at 04:18PM by cityoftreesandphds https://ift.tt/32PwYve
Thursday, July 23, 2020
For the first time ever, a live-attenuated therapeutic vaccine is being developed for herpes (HSV-2) and will enter US clinical trials sometime in 2021. If successful, this vaccine will serve as a functional cure for this disease.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment